Atlas Trials

Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?

Clinical trial NCT02768948 · COMPLETED

Trial details

NCT number
NCT02768948
Sponsor
Centre Hospitalier Universitaire de Nice
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetic Nephropathy
Start date
2017-05-05
Primary completion
2019-09-11
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.